82
C.-Y. Yang et al. / Fitoterapia 96 (2014) 81–87
spectrometer (Shimadzu, Kyoto, Japan). UV spectra were
conducted on a UV-2401A spectrophotometer (Shimadzu,
Kyoto, Japan). Electronic circular dichroism (ECD) spectra
were performed on an Applied Photophysics Chirascan instru-
ment (Agilent, America). IR spectra were collected on a Bio-Rad
FTS-135 spectrometer (Bio-Rad, Hercules, CA). 1D and 2D NMR
spectra were acquired using AM-400, DRX-500 or Advance
III-600 NMR spectrometers (Bruker, Bremerhaven, Germany)
with TMS as internal standard. Semi-preparative HPLC was
performed on a Waters Alliance 2695 (pump: Waters 600,
detector: Waters 2996) with a reversed-phase (RP) C18 column
(9.4 × 250 mm, 5 μm, Agilent). Silica gel (200–300 mesh,
Qingdao Makall group Co., Ltd; Qingdao, China), C18 (Merck,
Darmstadt, Germany) and Sephadex LH-20 (Amersham Bio-
science, Sweden) were used for column chromatography.
was purified through HPLC on a RP C18 column eluted with
MeOH–H2O (55:45) to generate 2 (12 mg) and 3 (30 mg).
Fr.5.4 (3.7 g) was chromatographed on a silica gel column
(100 g, 3.5 × 50 cm) using HCOOH–MeOH–CHCl3 (1:10:90) as
the eluent to give Frs.5.4.1–5.4.4. Fr.5.4.4 (2.2 g) was subjected to
a silica gel CC (40 g, 2.0 × 50 cm) eluted with H2O–MeOH–
EtOAc (0.5:5:95) to generate Frs.5.4.4.1–5.4.4.3. Fr.5.4.4.1
(130 mg) was separated on a sephadex LH-20 column (50 g,
1.4 × 150 cm) to produce compound 5 (5 mg). Fr.8 (15.0 g) was
fractionated by a MCI CHP 20P gel column (100 g, 2.54 × 40 cm)
eluted with MeOH–H2O (20:80, 40:60, 60:40, 80:20, 100:0) to
produce Frs.8.1–8.5. Fr.8.1 (5.5 g) was chromatographed on a
silica gel column (100 g, 4.0 × 50 cm) eluted with H2O–MeOH–
CHCl3 (2:20:80) to generate 7 (20 mg).
Nicotabacoside A (1): Colorless acicular crystal [MeOH–
H2O (1:1, v/v)], mp 107.2–108.2 °C; [α]1D6: +37.1 (c 0.20,
2.2. Plant material
MeOH); ECD (MeOH) Δε
+ 15.66, Δε
+ 6.29,
205
195
Δε + 7.56, Δε − 0.01; IR (KBr) vmax 3423, 1642,
212
231
The leaves of N. tabacum Linn. were collected from Luliang
County of Yunnan Province of China, on September 16, 2011
and identified by Prof. Dr. Li-Gong Lei, Kunming Institute of
Botany, Chinese Academy of Sciences. A voucher specimen (No.
2011-09-16) was deposited in the Laboratory of Antivirus and
Natural Medicinal Chemistry, Kunming Institute of Botany,
Chinese Academy of Sciences.
1439, 1374, 1167, 1077, 1031 cm−1 1H (400 MHz) and 13C
;
NMR (100 MHz) data (see Tables 1 and 3); HRESIMS m/z
407.2040 [M + Na]+ (calcd for C20H32O7Na, 407.2040,
0 mDa).
Crystal data of compound 1: C20H32O7·2H2O, M =
420.49, monoclinic, a = 21.4086 (7) Å, b = 7.3541 (3) Å,
c = 28.0134 (9) Å, α = 90.00°, β = 95.0100 (10)°, γ =
90.00°, V = 4393.6(3) Å3, T = 100 (2) K, space group C2,
Z = 8, μ (CuKα) = 0.830 mm−1, 15,414 reflections mea-
sured, 5780 independent reflections (Rint = 0.0565). The
final R1 values were 0.1023 (I N 2σ (I)) and 0.1054 (all data).
The final wR (F2) values were 0.2790 (I N 2σ (I)) and 0.2875
(all data). The goodness of fit on F2 was 1.368, flack
parameter was 0.2 (3), the Hooft parameter was 0.24 (13)
for 1820 Bijvoet pairs.
2.3. Extraction and isolation
The dried leaves of N. tabacum (3.5 kg) were extracted
with 90% EtOH at room temperature for 3 times, each for
72 h. All the extract was combined and condensed under
reduced pressure (b60 °C), which was partitioned between
EtOAc and H2O.
The EtOAc part (615 g) was subjected to silica gel column
chromatography (CC) (3.0 kg, 18.0 × 70 cm) using H2O–
MeOH–CHCl3 (0:0:100, 0:5:95, 0:10:90, 2:20:80, v/v) as the
eluent to afford Frs.1–8. Fr.4 (35.5 g) was fractionated by a MCI
CHP 20P gel column (310 g, 4.0 × 40 cm) eluted with MeOH–
H2O (20:80, 40:60, 60:40, 80:20, 100:0) to get Frs.4.1–4.5.
Nicotabacoside B (2): White powder; [α]1D7: −49.2 (c 0.09,
MeOH); ECD (MeOH) Δε
− 11.91, Δε
− 15.42,
195
200
Δε 218 + 0.98, Δε 228 − 0.33; IR (KBr) vmax 3473, 3406, 1643,
1443, 1373, 1163, 1079, 1031 cm−1 1H (400 MHz) and 13C
;
(100 MHz) NMR data (see Tables 1 and 3); HRESIMS m/z
407.2053 [M + Na]+ (calcd for C20H32O7Na, 407.2040, +
1.3 mDa).
Fr.4.3 (1.8 g) was subjected to
a silica gel CC (40 g,
2.0 × 50 cm) eluted with MeOH–CHCl3 (10:90) to provide
Frs.4.3.1–4.3.2. Fr.4.3.2 (538 mg) was separated on a sephadex
LH-20 column (50 g, 1.4 × 150 cm) to yield Frs.4.3.2.1–4.3.2.2.
Fr.4.3.2.1 (427 mg) was purified by HPLC on a RP C18 column
using MeOH–H2O (48:52) as the eluent to obtain compounds 8
(23 mg), 9 (8 mg), 10 (46 mg) and 11 (36 mg). Fr.5 (29.5 g)
was fractionated by a MCI CHP 20P gel column (310 g,
4.0 × 40 cm) eluted with MeOH–H2O (20:80, 40:60, 60:40,
80:20, 100:0) to produce Frs.5.1–5.5. Fr.5.2 (1.6 g) was
chromatographed on a RP C18 column (124 g, 2.54 × 40 cm)
eluted with MeOH–H2O (10:90, 30:70, 50:50, 70:30, 100:0) to
obtain Frs.5.2.1–5.2.7. Fr.5.2.7 (100 mg) was purified through
HPLC on a RP C18 column with MeCN–H2O (25:75) as mobile
phase to afford compound 6 (4 mg). Fr.5.3 (3.2 g) was
submitted to a silica gel CC (100 g, 4.0 × 50 cm) eluted with
H2O–MeOH–CHCl3 (0:10:90, 1.0:15:85) to give Frs.5.3.1–5.3.6.
Fr.5.3.3 (500 mg) was separated by HPLC on a RP C18 column
eluted with MeOH–H2O (72:28) to provide Fr.5.3.3.1 and
Fr.5.3.3.2. Fr.5.3.3.1 (60 mg) was purified by HPLC on a RP C18
column using MeCN–H2O (35:65) as the eluent to yield
compounds 1 (10 mg) and 4 (10 mg). Fr.5.3.3.2 (200 mg)
Nicotabacoside C (3): White powder; [α]1D6: −42.5 (c 0.60,
MeOH); ECD (MeOH) Δε 195 − 11.91, Δε 196 − 8.95, Δε 200
−
13.30, Δε 216 + 3.72, Δε 239 − 0.55; IR (KBr) vmax 3408, 1644,
1602, 1450, 1375, 1284, 1164, 1076, 1042, 1023 cm−1 1H
;
(400 MHz) and 13C (100 MHz) NMR data (see Tables 1 and 3);
HRESIMS m/z 407.2038 [M + Na]+ (calcd for C20H32O7Na,
407.2040, −0.2 mDa).
Nicotabacoside D (4): Colorless acicular crystals [MeOH–H2O
(6:4)], mp 195.0–196.0 ºC; [α]1D6: +5.8 (c 0.08, MeOH); UV
(MeOH) λmax (log ε) 241 (4.45) nm; ECD (MeOH) Δε 195 + 8.40,
Δε
− 4.44, Δε
+ 14.88, Δε
− 0.49; IR (KBr) vmax
210
239
259
3419, 1643, 1452, 1372, 1165, 1079, 1030 cm−1; 1H (400 MHz)
and 13C (100 MHz) NMR data are seen in Tables 2 and 3;
HRESIMS m/z 405.1879 [M + Na]+ (calcd for C20H30O7Na,
405.1884, −0.5 mDa).
Crystal data of compound 4: C20H30O7·H2O, M = 400.46,
monoclinic, a = 8.0041 (6) Å, b = 63.282 (5) Å, c = 8.9989
(7) Å, α = 90.00°, β = 116.076 (4)°, γ = 90.00°, V =
4094.1 (5) Å3, T = 100 (2) K, space group P21, Z = 8,
μ
(CuKα) = 0.831 mm−1
,
27,133 reflections measured,
12,552 independent reflections (Rint = 0.1413). The final